Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 212

Similar articles for PubMed (Select 18503965)

1.

B-type natriuretic peptide is a sensitive screening test for acute rejection in pediatric heart transplant patients.

Rossano JW, Denfield SW, Kim JJ, Price JF, Jefferies JL, Decker JA, Smith EO, Clunie SK, Towbin JA, Dreyer WJ.

J Heart Lung Transplant. 2008 Jun;27(6):649-54. doi: 10.1016/j.healun.2008.03.008. Epub 2008 Apr 24.

PMID:
18503965
2.

Usefulness of serial monitoring of B-type natriuretic peptide for the detection of acute rejection after heart transplantation.

Garrido IP, Pascual-Figal DA, Nicolás F, González-Carrillo MJ, Manzano-Fernández S, Sánchez-Mas J, Valdés-Chavarri M.

Am J Cardiol. 2009 Apr 15;103(8):1149-53. doi: 10.1016/j.amjcard.2009.01.008. Epub 2009 Feb 28.

PMID:
19361605
3.

Radioimmunometric assay of B-type natriuretic peptide (BNP) in heart transplantation: correlation between BNP determinations and biopsy grading of rejection.

Hervás I, Almenar L, Pérez-Pastor JL, Chirivella M, Osa A, Martínez-Dolz L, Bello P, Martí JF, Arnau MA, Vera F, Rueda J, Palencia M, Mateo A.

Nucl Med Commun. 2003 Aug;24(8):925-31.

PMID:
12869826
4.

Use of a highly sensitive assay for cardiac troponin T and N-terminal pro-brain natriuretic peptide to diagnose acute rejection in pediatric cardiac transplant recipients.

Dyer AK, Barnes AP, Fixler DE, Shah TK, Sutcliffe DL, Hashim I, Drazner MH, de Lemos JA.

Am Heart J. 2012 Apr;163(4):595-600. doi: 10.1016/j.ahj.2012.02.003.

PMID:
22520525
5.

Changes in serial B-type natriuretic peptide level independently predict cardiac allograft rejection.

Damodaran A, Dardas T, Wu AH, Dyke DB, Hummel SL, Cowger JA, Koelling TM.

J Heart Lung Transplant. 2012 Jul;31(7):708-14. doi: 10.1016/j.healun.2012.02.014. Epub 2012 Apr 12.

PMID:
22502810
6.

[B-type natriuretic peptide assessment in the diagnosis of rejection after pediatric heart transplant].

Sylos Cd, Azeka E, Kajita L, Benvenutti L, Strunz CC, Branco KC, Riso AA, Tanamati C, Jatene M, Barbero-Marcial M.

Arq Bras Cardiol. 2009 Mar;92(3):215-26. English, Spanish.

7.

Screening for rejection in symptomatic pediatric heart transplant recipients: the sensitivity of BNP.

Geiger M, Harake D, Halnon N, Alejos JC, Levi DS.

Pediatr Transplant. 2008 Aug;12(5):563-9. Epub 2007 Dec 16.

PMID:
18086251
8.

Prognostic value of brain natriuretic peptide in heart transplant patients.

Martinez-Dolz L, Almenar L, Moro J, Agüero J, Hervas I, Rueda J, Rivera M, Arnau MA, Mateo A, Salvador A.

J Heart Lung Transplant. 2007 Oct;26(10):986-91.

PMID:
17919617
9.
10.

The change in B-type natriuretic peptide levels over time predicts significant rejection in cardiac transplant recipients.

Kittleson MM, Skojec DV, Wittstein IS, Champion HC, Judge DP, Barouch LA, Halushka M, Hare JM, Kasper EK, Russell SD.

J Heart Lung Transplant. 2009 Jul;28(7):704-9. doi: 10.1016/j.healun.2009.04.019.

PMID:
19560699
11.

Value of plasma B-type natriuretic peptide as a marker for rejection in pediatric heart transplant recipients.

Lindblade CL, Chun DS, Darragh RK, Caldwell RL, Murphy DJ, Schamberger MS.

Am J Cardiol. 2005 Apr 1;95(7):909-11.

PMID:
15781032
12.

Value of brain natriuretic peptide after acute myocardial infarction.

Güneş Y, Okçün B, Kavlak E, Erbaş C, Karcier S.

Anadolu Kardiyol Derg. 2008 Jun;8(3):182-7.

13.

Predictive value of brain natriuretic peptide in the diagnosis of heart transplant rejection.

Arnau-Vives MA, Almenar L, Hervas I, Osa A, Martinez-Dolz L, Rueda J, Zorio E, Martinez-Ortiz De Urbina L, Perez JL, Mateo A, Palencia M.

J Heart Lung Transplant. 2004 Jul;23(7):850-6.

PMID:
15261180
14.

Gender-specific risk stratification with B-type natriuretic peptide levels in patients with acute dyspnea: insights from the B-type natriuretic peptide for acute shortness of breath evaluation study.

Christ M, Laule-Kilian K, Hochholzer W, Klima T, Breidthardt T, Perruchoud AP, Mueller C.

J Am Coll Cardiol. 2006 Nov 7;48(9):1808-12. Epub 2006 Oct 17.

15.

Time-dependent changes in B-type natriuretic peptide after heart transplantation: correlation with allograft rejection and function.

Bader FM, Rogers RK, Kfoury AG, Gilbert EM, Horne BD, Stehlik J, Renlund DG.

Congest Heart Fail. 2009 Mar-Apr;15(2):63-7. doi: 10.1111/j.1751-7133.2009.00055.x.

PMID:
19379451
16.

Prognostic role of brain natriuretic peptide in acute pulmonary embolism.

Kucher N, Printzen G, Goldhaber SZ.

Circulation. 2003 May 27;107(20):2545-7. Epub 2003 May 12.

17.

B-type natriuretic peptide as a marker of allograft rejection after heart transplantation.

Hammerer-Lercher A, Mair J, Antretter H, Ruttmann E, Poelzl G, Laufer G, Puschendorf B, Hangler H.

J Heart Lung Transplant. 2005 Sep;24(9):1444.

PMID:
16143273
18.

B-type natriuretic peptide testing for structural heart disease screening: a general population-based study.

Nakamura M, Tanaka F, Sato K, Segawa T, Nagano M.

J Card Fail. 2005 Dec;11(9):705-12. Erratum in: J Card Fail. 2006 Mar;12(2):170.

PMID:
16360967
19.

Use of B-type natriuretic peptide in the risk stratification of acute exacerbations of COPD.

Stolz D, Breidthardt T, Christ-Crain M, Bingisser R, Miedinger D, Leuppi J, Mueller B, Tamm M, Mueller C.

Chest. 2008 May;133(5):1088-94. doi: 10.1378/chest.07-1959. Epub 2008 Mar 13.

PMID:
18339792
20.

Ability of B-type natriuretic peptide in predicting postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting.

Ata Y, Turk T, Ay D, Eris C, Demir M, Ari H, Ata F, Yavuz S, Ozyazicioglu A.

Heart Surg Forum. 2009 Aug;12(4):E211-6. doi: 10.1532/HSF98.20091014.

PMID:
19683991
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk